XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1.98%2.19B | 1.40%549.83M | 1.68%551.13M | 2.11%546.44M | 2.76%543.62M | 6.37%2.15B | 2.71%542.25M | 4.08%542.04M | 8.10%535.15M | 11.12%529.03M |
Operating revenue | 1.98%2.19B | 1.40%549.83M | 1.68%551.13M | 2.11%546.44M | 2.76%543.62M | 6.37%2.15B | 2.71%542.25M | 4.08%542.04M | 8.10%535.15M | 11.12%529.03M |
Cost of revenue | 5.48%1.48B | 6.63%373.36M | 3.68%375.55M | 5.33%368.02M | 6.36%360.82M | 5.17%1.4B | 4.07%350.14M | 5.13%362.22M | 5.41%349.4M | 6.11%339.23M |
Gross profit | -4.58%713.27M | -8.14%176.47M | -2.36%175.58M | -3.95%178.42M | -3.69%182.81M | 8.69%747.48M | 0.31%192.11M | 2.04%179.82M | 13.55%185.75M | 21.37%189.8M |
Operating expense | -3.52%56.52M | -7.72%14.07M | -5.89%12.73M | -8.72%12.67M | 7.05%17.05M | -0.43%58.58M | 3.44%15.25M | 10.96%13.52M | -10.90%13.88M | -2.45%15.92M |
Selling and administrative expenses | -3.52%56.52M | -7.72%14.07M | -5.89%12.73M | -8.72%12.67M | 7.05%17.05M | -0.43%58.58M | 3.44%15.25M | 10.96%13.52M | -10.90%13.88M | -2.45%15.92M |
-General and administrative expense | -3.52%56.52M | -7.72%14.07M | -5.89%12.73M | -8.72%12.67M | 7.05%17.05M | -0.43%58.58M | 3.44%15.25M | 10.96%13.52M | -10.90%13.88M | -2.45%15.92M |
Operating profit | -4.67%656.75M | -8.18%162.4M | -2.07%162.85M | -3.56%165.75M | -4.67%165.76M | 9.54%688.9M | 0.05%176.86M | 1.38%166.3M | 16.12%171.87M | 24.15%173.88M |
Net non-operating interest income expense | -12.94%-168.54M | -14.55%-44.19M | -16.58%-42.73M | -12.37%-41.27M | -8.26%-40.36M | 3.56%-149.23M | -1.30%-38.58M | 5.14%-36.65M | 5.61%-36.72M | 4.70%-37.28M |
Non-operating interest expense | 12.94%168.54M | 14.55%44.19M | 16.58%42.73M | 12.37%41.27M | 8.26%40.36M | -3.56%149.23M | 1.30%38.58M | -5.14%36.65M | -5.61%36.72M | -4.70%37.28M |
Other net income (expense) | 81.73%56.66M | 98.69%54.08M | 89.87%-1.68M | -213.40%-19.27M | 565.27%23.52M | -81.96%31.18M | -54.13%27.22M | -1,186.34%-16.57M | -83.66%16.99M | -67.31%3.54M |
Gain on sale of security | 687,637.50%55M | 5,502,900.00%55.03M | ---- | -2,200.00%-23K | -102.90%-2K | -100.00%-8K | -100.00%-1K | -117.44%-75K | -100.00%-1K | 213.64%69K |
Other non- operating income (expenses) | -94.69%1.66M | -103.49%-949K | 89.83%-1.68M | -213.25%-19.24M | 578.57%23.53M | 173.01%31.19M | 216.00%27.22M | -860.01%-16.49M | 159.99%16.99M | -67.88%3.47M |
Income before tax | -4.55%544.87M | 4.10%172.28M | 4.75%118.45M | -30.84%105.21M | 6.27%148.92M | -11.77%570.85M | -16.43%165.5M | -8.89%113.08M | -28.61%152.14M | 25.39%140.13M |
Income tax | 10.46%5.24M | 52.87%1.76M | 420.57%670K | -64.35%1.02M | 90.15%1.8M | 176.42%4.74M | 350.66%1.15M | 83.36%-209K | 193.74%2.86M | 165.46%944K |
Earnings from equity interest net of tax | 12.77%1.95M | 5.81%546K | 1.57%454K | 22.77%469K | 25.19%482K | 9.56%1.73M | 14.67%516K | 31.09%447K | -6.60%382K | 1.58%385K |
Net income | -4.62%541.58M | 3.76%171.07M | 3.95%118.23M | -30.07%104.66M | 5.76%147.61M | -13.28%567.83M | -17.13%164.87M | -9.52%113.73M | -30.89%149.66M | 22.89%139.57M |
Net income continuous Operations | -4.62%541.58M | 3.76%171.07M | 3.95%118.23M | -30.07%104.66M | 5.76%147.61M | -13.28%567.83M | -17.13%164.87M | -9.52%113.73M | -30.89%149.66M | 22.89%139.57M |
Minority interest income | -6.60%14.03M | 0.82%4.43M | 1.17%3.04M | -31.75%2.71M | 5.38%3.86M | -13.35%15.03M | -17.37%4.39M | -11.56%3M | -32.25%3.97M | 32.04%3.66M |
Net income attributable to the parent company | -4.57%527.54M | 3.84%166.65M | 4.03%115.2M | -30.02%101.95M | 5.77%143.75M | -13.28%552.81M | -17.12%160.48M | -9.47%110.73M | -30.86%145.69M | 22.66%135.91M |
Preferred stock dividends | 0.00%3.69M | 0.00%922K | 0.00%922K | 0.00%922K | 0.00%922K | 0.00%3.69M | 0.00%922K | 0.00%922K | 0.00%922K | 0.00%922K |
Other preferred stock dividends | -66.52%75K | -239.68%-88K | 20.45%53K | -18.97%47K | -48.86%224K | -51.54%63K | -46.34%44K | 58K | ||
Net income attributable to common stockholders | -4.58%523.78M | 3.96%165.81M | 4.06%114.22M | -30.22%100.98M | 5.81%142.83M | -13.33%548.89M | -17.18%159.49M | -9.51%109.77M | -31.02%144.71M | 22.85%134.99M |
Basic earnings per share | -4.67%4.49 | 3.65%1.42 | 4.26%0.98 | -30.65%0.86 | 5.17%1.22 | -14.21%4.71 | -17.96%1.37 | -10.48%0.94 | -31.87%1.24 | 22.11%1.16 |
Diluted earnings per share | -4.67%4.49 | 3.65%1.42 | 4.26%0.98 | -30.65%0.86 | 5.17%1.22 | -14.05%4.71 | -17.96%1.37 | -10.48%0.94 | -31.87%1.24 | 22.11%1.16 |
Dividend per share | 5.00%5.88 | 5.00%1.47 | 5.00%1.47 | 5.00%1.47 | 5.00%1.47 | 19.79%5.6 | 12.00%1.4 | 12.00%1.4 | 28.74%1.4 | 28.74%1.4 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |